Description

Dlin-Kc2-Dma is a specialized cationic lipid compound widely recognized for its critical role in the formulation of lipid nanoparticles (LNPs). This compound matters as a key structural and functional component for the efficient encapsulation and delivery of nucleic acids, such as siRNA and mRNA. Pharmaceutical, biotechnology, and advanced therapeutic medicinal product (ATMP) developers need it to create next-generation delivery systems for vaccines and genetic therapies.

Application

• Primary component in the formulation of lipid nanoparticles (LNPs) for nucleic acid delivery.
• Critical excipient for the development of mRNA-based vaccines and therapeutics.
• Essential material for siRNA delivery systems targeting various genetic disorders.
• Used in research and development of non-viral gene therapy vectors.
• Key ingredient in liposomal formulations for enhanced drug delivery.
• Facilitates cell-specific targeting in advanced drug delivery platforms.
• Employed in preclinical and clinical-stage pharmaceutical development.

Basic Information

Item	Detail
Product Name	Dlin-Kc2-Dma
CAS No.	1190197-97-7
Molecular Formula	Contact for details
Molecular Weight	Contact for details
Synonyms	Dlin-KC2-DMA; DLin-KC2-DMA; 1,2-Dilinoleyloxy-3-dimethylaminopropane; KC2 Lipid; Cationic Lipid KC2; DLinDMA analog; DLin-K-DMA derivative; Heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate (IUPAC-like)
EINECS	Contact for details

Quality Control

Our Dlin-Kc2-Dma is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity, suitable for pharmaceutical development. Each lot is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We adhere to cGMP guidelines where applicable, and our quality protocols are designed to meet the stringent requirements of preclinical and clinical applications.

Storage

Preserve in a tightly closed container, protected from light. Store the product in its original packaging under an inert atmosphere (e.g., nitrogen or argon) at recommended cold temperatures (e.g., -20°C or as specified on the label) to maintain stability. The storage area should be dry, well-ventilated, and free from oxidizing agents.

Specification

Item	Specification
Appearance	Colorless to pale yellow liquid or solid
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
Related Substances (HPLC)	Total impurities ≤ 5.0%
Residual Solvents (GC)	Meets ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.